HOME >> BIOLOGY >> NEWS
ESF EURYI award winner aims to stop cancer cells reading their own DNA

A promising new line in anti-cancer therapy by blocking the molecular motors involved in copying genetic information during cell division is being pursued by young Dutch researcher Dr. Nynke Dekker in one of this years EURYI award winning projects sponsored by the European Science Foundation (ESF) and the European Heads of Research Councils (EuroHORCS). Dekker and her team are trying to stop tumor development by interfering with the molecular motors that copy DNA during cell division. This will cut off the genetic information flow that tumours need to grow, and could complement existing cancer therapies, while in the longer term bringing the promise of improved outcomes with greatly reduced side effects.

There are three primary ways of treating cancer at present, and these have fundamentally changed little in 30 years. In the case of solid tumours, surgery can be used to cut out the cancerous tissue, while radiation therapy can kill the malignant cells, and chemotherapy stops them dividing. Dekkers work is aiming towards a new generation of drugs that target cancer cells much more specifically than traditional chemotherapy, avoiding side effects such as temporary hair loss.

Dekker is focusing on an enzyme called Topoisomerase IB that plays a key role in some of the molecular motors involved in the processes of DNA and RNA copying during cell division. These are responsible for reading the genetic code and making sure it is encoded correctly in the daughter cell. In healthy cells it is important that this process works normally, but in cancer cells it is a natural target for disruptive therapy. Specifically targeting these molecular motors in cancer cells would then prevent the cancer cells from growing into a larger tumor, said Dekker. This molecular copying machinery, constructed mostly out of proteins, in effect walks along the DNA double helix reading the genetic code so that it can be copied accurately into new DNA during division. Other compo
'"/>

Contact: Thomas Lau
tlau@esf.org
33-388-762-158
European Science Foundation
9-Aug-2007


Page: 1 2

Related biology news :

1. Universes stringy birth revealed by young Czech scientist in EURYI winning project
2. 2007 EURYI: 20 young researchers to receive Nobel Prize-sized awards for breakthrough ideas
3. EURYI to showcase the future of European science in Prague
4. Germans do well in the third round of EURYI Awards
5. EURYI expands horizons for young scientific researchers in Europe
6. 2005 EURYI Awards highlight the future excellence of science in Europe
7. EURYI award 2005
8. Doernbecher Childrens Hospital scientist earns coveted Javits award
9. Gilbert Foundation and American Fed for Aging Research award grants on Alzheimers disease
10. Argonne wins three R&D 100 awards for innovative technologies
11. ASBMB taps 8 scientists and 1 politician for top awards

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/7/2018)... (PRWEB) , ... September 05, 2018 , ... ... Platform for a mAb manufacturing facility late last year, IPS-Integrated Project Services, LLC ... the manufacturing of autologous cell therapies. The iCON solution provides a pre-fabricated modular ...
(Date:8/31/2018)... ... August 30, 2018 , ... R3 Stem Cell, the ... for new clients. The freezers are very convenient for practices to maintain regenerative ... consist of amniotic and umbilical cord tissue. They are stored at -80 degrees ...
(Date:8/31/2018)... ... August 30, 2018 , ... USDM Life Sciences , the ... and healthcare industries, has received the 2018 Services Partner of the Year, Awarded for ... Box SVP of Business Development and Platform Sales, Niall Wall and received by USDM ...
Breaking Biology News(10 mins):
(Date:9/12/2018)... ... September 11, 2018 , ... ... add flat sheet Forward Osmosis (FO) membranes from Fluid Technology Solutions (FTS H2O) ... by FTS H2O are constructed from cellulose triacetate (CTA) material. The highly hydrophilic ...
(Date:9/7/2018)... ... September 06, 2018 , ... The Discovery on ... meeting of “The industry’s preeminent event on novel drug targets.” BellBrook Labs’ high ... to study these emerging targets in a quest to find new treatments for ...
(Date:9/7/2018)... ... September 06, 2018 , ... Akadeum Life Sciences today announced it has ... an executive and leader of numerous biotech companies. , He most recently served ... acquired by Thompson Street Capital in St. Louis, MO. Prior to ISTO, he ...
(Date:8/31/2018)... ... August 30, 2018 , ... Small, wireless and networked describes more than ... getting connected, too. Draper’s latest system is tiny in size, but is poised to ... factor in the new implant design is the growing awareness that disease often involves ...
Breaking Biology Technology:
Cached News: